Orange Book product · Generic (ANDA)
CLOFARABINE
CLOFARABINE
At a glance
Feb 22, 2019
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 22, 2019
7 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
CLOFARABINE
Strength
20MG/20ML (1MG/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
AP
Application
ANDA 212034
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CLOFARABINE
- 2004CLOLARBrand (NDA)
NDA 021673 · GENZYME
- 2025CLOFARABINEGeneric (ANDA)
ANDA 216233 · SCINOPHARM TAIWAN
- 2022CLOFARABINEGeneric (ANDA)
ANDA 212457 · EUGIA PHARMA
- 2020CLOFARABINEGeneric (ANDA)
ANDA 213461 · MEITHEAL
- 2018CLOFARABINEGeneric (ANDA)
ANDA 210283 · HOSPIRA
- 2018CLOFARABINEGeneric (ANDA)
ANDA 207831 · GLAND
- 2018CLOFARABINEGeneric (ANDA)
ANDA 210270 · INGENUS PHARMS LLC
- 2017CLOFARABINEGeneric (ANDA)
ANDA 209775 · MSN
- 2017CLOFARABINEGeneric (ANDA)
ANDA 208857 · AMNEAL
- 2017CLOFARABINEGeneric (ANDA)
ANDA 205375 · DR REDDYS
- 2017CLOFARABINEGeneric (ANDA)
ANDA 208860 · PHARMOBEDIENT
- 2017CLOFARABINEGeneric (ANDA)
ANDA 204029 · ABON PHARMS LLC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
